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Introduction {#sec1}
============

Alterations in histone methylation instruct developmental gene-expression programs that enable proliferating progenitor cells to exit the cell cycle and differentiate. These changes are mediated by conserved, multiprotein macromolecules that "write" and "read" histone methylation marks, such as Set1/COMPASS-like complexes ([@bib38]), Polycomb repressor complexes ([@bib32]), and assemblies containing the histone methyltransferases (HMTs) G9a and GLP ([@bib39]). Developmental regulation of specific genomic loci involves complex physical interactions involving tissue-specific transcription factors (TFs), non-coding RNA, and other co-factors ([@bib18]). Histone methylation in pluripotency-related gene regulation has been characterized extensively ([@bib49]), yet the composition of relevant HMT complexes and, specifically, the identity of physically associated co-regulators that modulate activity during cellular differentiation are incompletely defined.

G9a/EHMT2 and GLP/EHMT1 are responsible for dimethylated H3K9 (H3K9me2) in transcriptionally repressed euchromatin ([@bib42]) and are essential for cell differentiation during embryogenesis ([@bib39]). In embryonic stem cells (ESCs), G9a/GLP facilitate the long-term silencing of pluripotency-associated genes ([@bib43]). In hematopoietic stem and progenitor cells (HSPCs), inhibition of G9a/GLP delays lineage commitment and prevents the formation of large H3K9me2 chromatin territories ([@bib13]). In neural contexts, loss of G9a or GLP in the mouse forebrain reactivates neural progenitor gene expression, leading to cognitive and adaptive behavioral defects ([@bib36]). Disruption of the GLP/*EHMT1* gene in humans is associated with congenital intellectual disability ([@bib23]), and heterozygous GLP/*EHMT1* knockout mice exhibit behavioral and neurodevelopmental abnormalities ([@bib2], [@bib3]). Although G9a/GLP-associated proteins have been reported ([@bib6], [@bib29], [@bib46]), their precise contributions to G9a/GLP-mediated neural differentiation are largely unknown.

Retinal progenitor cells (RPCs) are proliferative multipotent cells that produce differentiated cells in an evolutionary conserved birth order ([@bib5], [@bib11]). RPC proliferation and differentiation must be closely integrated and coordinated with eye growth for proper morphology and structure ([@bib17], [@bib52]), with impaired proliferative capacity resulting in microphthalmia, degeneration, and visual impairment ([@bib26]). RPC differentiation requires G9a/H3K9me2-mediated suppression of genes that sustain a proliferative multipotent state ([@bib21]), including Vsx2/Chx10, a TF uniformly expressed in fully multipotent RPCs ([@bib8], [@bib16], [@bib47]), and Ccnd1/Cyclin D1, the predominant D-cyclin in the developing retina ([@bib4]). Co-regulators that facilitate G9a/H3K9me2-mediated silencing during neurogenesis are unknown.

High-grade myopia involves progressive axial elongation of the eye that predisposes to degeneration and blindness. Genetic factors linked to high-grade myopia ([@bib19]) include mutations in the C2H2-like zinc finger (ZF) protein ZNF644, which segregates with autosomal dominant inheritance ([@bib37]). These findings suggest a role for ZNF644 in maintaining proper eye morphology and/or growth, yet its function in neural contexts is currently uncharacterized.

To better understand the molecular basis of histone methylation, we applied a lentiviral-based affinity purification and mass spectrometry (AP-MS) approach to isolate protein complexes that "write" and/or "read" histone methylation. We found that ZNF644 physically interacts with G9a and GLP and serves as a co-regulator of H3K9me2. By characterizing zebrafish ZNF644 orthologs *znf644a* and *znf644b*, we pinpointed roles for these genes in regulating G9a/H3K9me2-mediated silencing in neural progenitor cells. Loss-of-function experiments demonstrated roles for *znf644a* and *znf644b* in maintaining cell viability and ensuring the proper differentiation of retinal neurons, respectively, both of which were dependent on functional cooperativity and physical binding to G9a. Additional evidence suggested that the functions of *g9a* and *znf644a*/*b* are recapitulated in midbrain progenitor cells, suggesting a common gene-silencing complex mediating differentiation in distinct neuronal progenitor populations. Collectively, our findings highlight G9a-ZNF644 as a critical regulator of gene silencing and cell-fate transitions during neural differentiation.

Results {#sec2}
=======

ZNF644 Is a Co-regulator of Histone Methylation {#sec2.1}
-----------------------------------------------

We previously described a systematic AP-MS approach, based on stable lentivirus-based expression of epitope-tagged proteins, to characterize stable protein complexes involved in chromatin and transcriptional regulation ([@bib30], [@bib33]). As part of a larger study ([@bib31]), we targeted human HMT protein complexes linked to histone methylation during development. These included confirmed and putative homologs of Polycomb, Set1/COMPASS, and G9a/GLP-containing protein complexes ([Table S1](#mmc2){ref-type="supplementary-material"}). We created a scored physical interaction map encompassing components of histone methylation-related protein complexes with emphasis on regulators of developmental gene expression. Our dataset comprised 33 replicate AP-MS analyses of 25 histone methylation-related and eight transcription-related proteins.

In addition to accurately recapitulating established transcriptional assemblies, such as Mediator ([@bib14]), RNA polymerase II (RNAPII) ([@bib33]), and cleavage and polyadenylation-specific termination factor ([@bib22]) ([Figure 1](#fig1){ref-type="fig"} and [Table S1](#mmc2){ref-type="supplementary-material"}), we identified dozens of previously unknown associations among a filtered network of 573 interactions. Pairwise hierarchical clustering of the highly correlated interaction profiles of the different bait proteins revealed components residing within the same complex(es) ([Figure 1](#fig1){ref-type="fig"}B). Most (312 of 428, 72.9%) of the annotated interactions detected were corroborated in public protein-protein interaction repositories such as BioGRID ([@bib12]) and iRefWeb ([@bib45]), suggesting a high-confidence interaction network.

In addition to its known dimerization partner GLP, affinity-tagged G9a reproducibly co-purified the C2H2-like ZF proteins, WIZ and ZNF644 ([Figure 1](#fig1){ref-type="fig"}C). WIZ was previously reported to interact with G9a/GLP in ESCs via association of the SET domains of G9a/GLP with an atypical C2H2-like ZF motif in WIZ ([@bib46]). ZNF644 contains a highly similar atypical C2H2-like ZF motif, and GFP-tagged full-length ZNF644 as well as an isoform comprising the atypical ZF region (ZF8) was sufficient to co-purify G9a/GLP and WIZ ([Figure 1](#fig1){ref-type="fig"}D). In addition, mutations in the putative zinc ion-chelating residues of the atypical ZF motif (C1263A or H1283A) abolished complex formation ([Figure 1](#fig1){ref-type="fig"}D). The shortened ZF8 region of ZNF644, expressed as a recombinant glutathione S-transferase (GST)-fusion protein, efficiently pulled down recombinant His-tagged G9a SET domain homodimer, but not the C1263A or H1283A mutants ([Figure 1](#fig1){ref-type="fig"}E). Small hairpin RNA (shRNA)-mediated knockdown of either G9a or ZNF644 significantly and specifically reduced H3K9me2 ([Figures 1](#fig1){ref-type="fig"}F and [S1](#mmc1){ref-type="supplementary-material"}A). Collectively, these data demonstrate that ZNF644 binds to G9a/GLP and co-regulates H3K9me2.

*znf644a* and *znf644b* Are Expressed in Zebrafish Retina and Midbrain Progenitors {#sec2.2}
----------------------------------------------------------------------------------

HMT-related proteins are widely conserved ([@bib34]), allowing functional evaluation in model organisms. In zebrafish, *g9a* is broadly expressed during embryogenesis, and antisense splice-block morpholinos (MOs; g9a-MO) disrupting its function cause severe morphological defects, including reductions in eye and brain size ([@bib35]). We identified two zebrafish ZNF644 orthologs with 19.6% and 27.1% amino acid identity, *znf644a* and *znf644b*, respectively ([Figure 2](#fig2){ref-type="fig"}A), that contain atypical C2H2-like ZF motifs, suggesting conserved physical association with G9a/GLP. Indeed, AP-MS assays based on GFP-tagged zebrafish Znf644a or Znf644b proteins in HEK293 cells confirmed the ability to interact with G9a/GLP and WIZ (data not shown). Throughout embryogenesis, *znf644a* and *znf644b* mRNAs were expressed in most tissues, with slightly higher levels in the neuroepithelium of the retina and midbrain at 24 hr post fertilization (hpf) that was reduced by 48 hpf ([Figures 2](#fig2){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}B--S1D). Since the 24-hpf retina is largely composed of proliferating RPCs on the verge of differentiation ([@bib1], [@bib27]), we analyzed the developing retina to investigate potential functional cooperatively with *g9a*.

The Forming Retina and Midbrain Are Disrupted in *znf644a* or *znf644b* Morphants {#sec2.3}
---------------------------------------------------------------------------------

Loss-of-function studies using g9a-MO were consistent with previous reports ([@bib35]) in that these morphants showed severe morphological abnormalities in a dose-dependent manner ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). Although overall far less severe, splice-block MOs targeted against *znf644a* (znf644a-MO) or *znf644b* (znf644b-MO) showed significant dose-dependent reductions in eye size (microphthalmia) and disrupted midbrain morphology ([Figure 2](#fig2){ref-type="fig"}C). Mismatch control MOs showed no discernible phenotypes (data not shown), supporting targeting specificity. MO injection doses eliciting a ∼50% reduction in retinal cross-sectional area ([Figure 2](#fig2){ref-type="fig"}D) corresponded to a 57% reduction in *znf644a,* nearly complete splicing disruption of *znf644b*, and ∼35% drop in *g9a* ([Figure 2](#fig2){ref-type="fig"}E and data not shown). Co-injection of cognate mRNA fully rescued the *znf644a* morphant defect and, to a lesser but still appreciable degree, *znf644b* morphants ([Figures S2](#mmc1){ref-type="supplementary-material"}C and S2D), further confirming targeting specificity. These data highlight the developing retina and midbrain as neural structures dependent on coordinate *g9a*/*znf644a*/*znf644b* function.

*Znf644a* and *znf644b* Regulate Gene Silencing in the Retina via H3K9me2 {#sec2.4}
-------------------------------------------------------------------------

To assess the extent to which *znf644a* and *znf644b* affect H3K9me2 in vivo, we isolated cells from the head regions (heterogeneous mixture of retinal, brain, and other cell types) of *znf644a* and *znf644b* morphant embryos at 48 hpf and mapped the positioning of H3K9me2 marks by chromatin immunoprecipitation (ChIP) sequencing (GEO: [GSE63225](ncbi-geo:GSE63225){#intref0010}). H3K9me2 peaks near transcriptional start sites (TSSs), which were prominent in control embryos, were largely depleted in *znf644a* and *znf644b* morphants ([Figures 3](#fig3){ref-type="fig"}A and 3B; [Table S1](#mmc2){ref-type="supplementary-material"}), consistent with roles in the global regulation of H3K9me2.

Although some affected H3K9me2 peaks localized near genes implicated in neural development ([Table S1](#mmc2){ref-type="supplementary-material"}), sample heterogeneity likely precluded sampling of specific loci relevant to neural progenitor cell subpopulations. We therefore performed targeted investigations of the *vsx2* and *ccnd1* genes, two key regulators of multipotency and proliferation reported to be suppressed by G9a/H3K9me2 in mouse RPCs ([@bib21]). ChIP-PCR assays of zebrafish *vsx2* and *ccnd1* revealed reductions in H3K9me2 in the proximal promoters of *vsx2* and *ccnd1* in *znf644a* and *znf644b* morphant embryos ([Figure 3](#fig3){ref-type="fig"}C). In addition, these defects in H3K9me2 coincided with aberrantly mislocalized *vsx2* and *ccnd1* expression throughout the central retina at 48 hpf ([Figure 3](#fig3){ref-type="fig"}D), with similar changes observed in *g9a* morphant retinas ([Figures S3](#mmc1){ref-type="supplementary-material"}D and S3E). Collectively, these data demonstrate shared roles for *znf644a* and *znf644b* in H3K9me2-mediated gene silencing in RPCs.

*znf644a* and *znf644b* Suppress Neural Progenitor Gene Expression and Proliferation {#sec2.5}
------------------------------------------------------------------------------------

To distinguish whether mislocalized expression of vsx2 and ccnd1 simply represented failed gene silencing during retinal differentiation or a maintained proliferative progenitor identity, we examined additional multipotency (*rx3*, *otx2*) and proneural (*ath5*) markers ([@bib40]). Strikingly, *znf644a* morphants exhibited elevated and persistent expression of *rx3*, *ath5*, and *otx2* ([Figure 3](#fig3){ref-type="fig"}D), consistent with continued expression of multiple genes that typify the RPC expression program. In contrast, *znf644b* morphants showed minimal changes in *rx3* and *ath5* expression, but elevated *otx2* expression ([Figure 3](#fig3){ref-type="fig"}D), suggesting the deregulated expression of only a subset of RPC-specific genes. These changes in gene expression were rescued by co-injection of cognate mRNAs ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). Together, these data suggest at least partially non-overlapping requirements for *znf644a* and *znf644b* in suppressing the RPC gene-expression program.

We assessed the proliferative state of retinal cells in the morphants by quantitating 5′-bromo-2-deoxyuridine (BrdU)^+^ (S phase), phospho-histone H3 (pH3)^+^ (mitotic), and proliferating cell nuclear antigen (PCNA)^+^ cells (cycling cells). While the central retina of wild-type (WT) embryos contained few BrdU^+^ cells (0.23 ± 0.04 cells/μm^2^) and low PCNA expression at 48 hpf, there was an order-of-magnitude increase in the number of central BrdU^+^ cells (1.86 ± 0.29 cells/μm^2^) and markedly increased PCNA levels in *znf644a* morphants ([Figures 4](#fig4){ref-type="fig"}A and 4B). Likewise, *znf644b* morphants showed a significant (∼3.5-fold) increase in BrdU^+^ cells (0.81 ± 0.28 cells/μm^2^) and elevated PCNA ([Figures 4](#fig4){ref-type="fig"}A and 4B); however, the number of pH3^+^ cells was largely unchanged in the *znf644a* or *znf644b* morphant central retina, although a decreasing trend in *znf644a* morphants was noted ([Figures 4](#fig4){ref-type="fig"}C and 4D). In contrast, a substantial number of pH3^+^ cells persisted in the central retina at 72 hpf in *znf644a* morphants, but not *znf644b* morphants, compared with controls, where none were observed ([Figures 4](#fig4){ref-type="fig"}C--4E). Likewise, *g9a* morphant retinas exhibited similar increases in the number of proliferating cells that persisted in the central retina into late development ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). Collectively, these results establish roles for *znf644a* and *znf644b* in suppressing retinal cell proliferation.

CRISPR/Cas9 gene editing provided additional confirmation of *znf644b* morpholino target specificity ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Compared with phenotypically normal F1 embryos that were heterozygous for targeted mutations, embryos with two mutant (e.g., frameshift) alleles showed significantly reduced brain and retinal growth and elevated expression of *ccnd1* ([Figure S5](#mmc1){ref-type="supplementary-material"}B), coinciding with the presence of pH3+ cycling cells in the central retina at 48 hpf ([Figure S5](#mmc1){ref-type="supplementary-material"}C). Thus, results from an independent genetic loss-of-function approach are consistent with the phenotype observed in the *znf644b* morphants.

Consistent with the prolonged proliferation and maintained RPC gene-expression program, the central retinas of *znf644a* morphants lacked various types of differentiated neurons, as late as 48--72 hpf, including protein kinase C (PKC)^+^ bipolar neurons, GABA^+^ amacrine cells, and Zpr1^+^ cone photoreceptor cells ([Figure 4](#fig4){ref-type="fig"}F; data not shown). A similar lack of differentiated retinal neurons was likewise observed in *g9a* morphants ([Figure S4](#mmc1){ref-type="supplementary-material"}C). In contrast, the persistent expression of *vsx2* and *ccnd1* notwithstanding, *znf644b* morphant retinas, as a population, formed differentiated neurons by 48--72 hpf ([Figure 4](#fig4){ref-type="fig"}F and data not shown). These data imply distinct regulatory requirements for *znf644a* and *znf644b* vis-à-vis cellular differentiation in the retina.

*znf644a* Morphant Retinas Preserve Characteristics of Proliferative Progenitors {#sec2.6}
--------------------------------------------------------------------------------

To further characterize the *znf644a* morphant retina, we assessed the temporal emergence of RGCs and amacrine cells, which are among the first-born differentiated retinal cells ([@bib1], [@bib27]). Isl2b^+^ RGCs and Pax6^+^ amacrine cells, which are normally amply visible by 48 hpf, were not detected in *znf644a* morphant retinas until ∼72 hpf ([Figure 5](#fig5){ref-type="fig"}A), consistent with delayed onset of differentiation. Rather, the *znf644a* morphant retinas were also largely composed of Vsx2^+^ cells at 48 hpf, suggestive of a maintained RPC identity ([Figure 5](#fig5){ref-type="fig"}A). We also detected H3K9me2^+^ nuclei among differentiated cells of the ganglion and inner nuclear layer at 72 hpf ([Figure 5](#fig5){ref-type="fig"}A), reflecting global increases in H3K9me2 during differentiation. However, *znf644a* morphant retinas lacked H3K9me2^+^ nuclei even at 72 hpf ([Figure 5](#fig5){ref-type="fig"}A), suggesting that H3K9me2^+^ nuclei emerge downstream of cell-cycle exit within differentiated retinal neuron populations.

To confirm an RPC-specific role, we transplanted *znf644a* morphant donor cells (membrane-GFP^+^) into WT host embryos, thereby generating chimeric retinas. We observed a significant (21.6%) increase in pH3^+^ cells in donor cells (76 cells in total; n = 2) compared with an absence of pH3^+^ cells in embryos with control donor cells (94 cells in total; n = 2) ([Figures S4](#mmc1){ref-type="supplementary-material"}D and S4E), indicating an RPC-autonomous role of *znf644a*.

Impaired Viability of Differentiated Neurons in *znf644b* Morphant Retinas {#sec2.7}
--------------------------------------------------------------------------

Misexpression of proliferation genes during differentiation, as observed in *znf644b* morphants, is known to cause apoptosis ([@bib7], [@bib9], [@bib24], [@bib53]). Indeed, we observed increased cleaved Caspase3 in differentiated regions of *znf644b* morphant retinas at 72 hpf (28.7 ± 10.3) relative to WT retinas (2.0 ± 0.0; [Figures 5](#fig5){ref-type="fig"}B and 5C). High levels of apoptotic cells were seen in *g9a* morphant retinas not only at 72 hpf (67.0 ± 10.8), but also at earlier time points ([Figures 5](#fig5){ref-type="fig"}B and 5C). Cleaved Caspase3 was rescued in *znf644b* and *g9a* morphants by co-injecting a morpholino targeting p53 (p53-MO), suggesting intrinsic apoptosis pathway activation ([Figures 5](#fig5){ref-type="fig"}B and 5C). We also found evidence of concurrent expression of Pax6, a marker for differentiated amacrine and ganglion cells, and PCNA in *znf644b* morphant retinal cells at 56 hpf, coinciding with the onset of excessive cell death ([Figure S5](#mmc1){ref-type="supplementary-material"}E). Overall, these data suggest *znf644b* function is required to maintain the long-term viability of differentiated retinal cells, at least in part through H3K9me2-dependent repression of progenitor and/or cell-cycle genes.

Extensive Functional Cooperativity between *g9a*, *znf644a*, and *znf644b* {#sec2.8}
--------------------------------------------------------------------------

We used a genetic cooperativity approach wherein subphenotypic doses of MOs that individually do not yield observable developmental defects were co-injected to reveal potentially additive or synergistic effects. Co-injected subphenotypic g9a-MO and znf644b-MO gave rise to a *g9a* morphant-like phenotype with a substantial number of Caspase3^+^ apoptotic cells emerging early in the central retina ([Figure 6](#fig6){ref-type="fig"}A). Similar cooperativity occurred in mosaic retinas derived from in vivo cell transplantation assays, where a higher incidence (14.6%) of apoptosis was observed among retinal cells derived from co-injected subphenotypic g9a-MO plus znf644b-MO GFP^+^ donor cells (123 cells in total; n = 4) ([Figures S4](#mmc1){ref-type="supplementary-material"}F--S4H), compared with only 0.56% subphenotypic g9a-MO GFP^+^ donor cells (142 cells in total; n = 2) or 3.58% subphenotypic znf644b-MO GFP^+^ donor cells (139 cells in total; n = 3). These data suggest a cell-autonomous role for *g9a* and *znf644b* in maintaining retinal cell viability.

The number of PCNA^+^ cells localized to the peripheral ciliary marginal zones (CMZ) in control retinas was 64.4 ± 10.2 cells per section (n = 5), with none seen in the central retina in control or single MO-injected embryos at subphenotypic doses. However, embryos co-injected with subphenotypic doses of znf644b-MO and g9a-MO showed modestly increased PCNA^+^ cell numbers (74.0 ± 19.7 cells/section; n = 2), but only at the retinal periphery, while no change was observed in the central retina, which correlated with a modest effect in *vsx2* expression ([Figure 6](#fig6){ref-type="fig"}B). In contrast, co-injection of znf644a-MO and g9a-MO led to a synergistic increase in PCNA^+^ cells (129.0 ± 22.6 cells/section; n = 3) throughout the central retina at 48 hpf ([Figure 6](#fig6){ref-type="fig"}B), comparable with full *znf644a* morphant retinas ([Figure 4](#fig4){ref-type="fig"}A), yet without any observable effects on cell viability ([Figure 6](#fig6){ref-type="fig"}A) and with minimal changes in *vsx2* expression ([Figure 6](#fig6){ref-type="fig"}B). In addition, compared with controls, where pH3^+^ cells (17.0 ± 1.0; n = 3) and BrdU^+^ cells (15.3 ± 6.4; n = 3) were confined primarily to the marginal zone, co-injected subphenotypic doses of g9a-MO and znf644b-MO resulted in marked increased levels in pH3^+^ (50.6 ± 1.5; n = 3) and BrdU^+^ cells (31.0 ± 12.5; n = 3) and mislocalized *ccnd1* expression across the entire central retina and margin ([Figure S6](#mmc1){ref-type="supplementary-material"}B). Co-injection of g9a-MO and znf644a-MO resulted in similar overall changes ([Figure S6](#mmc1){ref-type="supplementary-material"}B). These data suggest that extensive functional cooperativity between *g9a* and *znf644b* or *znf644a* maintains the viability of differentiated retinal cells or suppresses a prolonged proliferative state in the retina, respectively.

The misexpression of *vsx2* and *ccnd1* and prolonged retinal cell proliferation in *znf644a* and *znf644b* morphant retinas at 48 hpf ([Figures 3](#fig3){ref-type="fig"}A, [4](#fig4){ref-type="fig"}A, and 4B) led us to investigate the role of functional cooperatively among these paralogs in suppressing RPC identity. As seen in *znf644a* and *znf644b* morphants ([Figure 3](#fig3){ref-type="fig"}A), co-injection of subphenotypic doses of znf644a-MO plus znf644b-MO resulted in mislocalized *vsx2* and *ccnd1* expression throughout the central retina at 48 hpf ([Figures 6](#fig6){ref-type="fig"}B and [S6](#mmc1){ref-type="supplementary-material"}A), consistent with functional cooperativity. In addition, increased numbers of PCNA^+^ (129.3 ± 25.2 cells/section; n = 6), pH3^+^ (33.0 ± 6.2; n = 3), and BrdU^+^ (42.0 ± 9.8; n = 3) cells were evident throughout the central retina ([Figures 6](#fig6){ref-type="fig"}B and [S6](#mmc1){ref-type="supplementary-material"}B), suggesting that *znf644a* and *znf644b* work together to suppress RPC gene expression and retinal cell proliferation.

Human ZNF644 Rescues *znf644a* and *znf644b* Morphant Phenotypes {#sec2.9}
----------------------------------------------------------------

To assess the conservation of human and zebrafish ZNF644 orthologs, we performed functional complementation assays. Full-length native version of human ZNF644 rescued the retinal defects observed in both the *znf644a* and *znf644b* morphant retinas; specifically, mislocalized expression of *vsx2* and elevated apoptosis in *znf644b* morphants ([Figures 6](#fig6){ref-type="fig"}D), and the mislocalized expression of *vsx2*, prolonged cellular proliferation, and lack of differentiated neurons in *znf644a* morphants ([Figures 6](#fig6){ref-type="fig"}C and [S4](#mmc1){ref-type="supplementary-material"}F). In contrast, the C1263A and H1283A mutants failed to rescue as efficiently ([Figures 6](#fig6){ref-type="fig"}C, 6D, [S4](#mmc1){ref-type="supplementary-material"}C, and S4D; data not shown). These data establish functional conservation of human ZNF644 with both zebrafish paralogs and further demonstrate the critical importance of physical association with G9a to ZNF644 function.

Retinal Defects in *znf644a* and *znf644b* Morphants Are Recapitulated in the Midbrain {#sec2.10}
--------------------------------------------------------------------------------------

The cellular and molecular defects of *g9a* and *znf644* morphant retinas were recapitulated in the midbrain, which, unlike other neural regions ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3C), showed more conspicuous morphological defects. Specifically, *znf644a* and *znf644b* morphant midbrains exhibited upregulated and mislocalized expression of *ccnd1* at 48 hpf ([Figure 7](#fig7){ref-type="fig"}A). Strikingly, combined subphenotypic doses of g9a-MO, znf644a-MO, or znf644b-MO again gave rise to mislocalized *ccnd1* expression in midbrain cells at 48 hpf ([Figure S6](#mmc1){ref-type="supplementary-material"}A), suggesting cooperative roles in gene suppression in the midbrain. As in the retina, *g9a* and *znf644b* morphants exhibited increased apoptosis in the midbrain, which was again rescued by co-injection of p53-MO ([Figure 7](#fig7){ref-type="fig"}B). Moreover, *znf644a* morphants exhibited prolonged PCNA expression and elevated numbers of pH3^+^ cells throughout the midbrain ([Figure 7](#fig7){ref-type="fig"}C and data not shown). Collectively, these data provide evidence that the cooperative functions of *g9a*, *znf644a*, and *znf644b* in the retina are recapitulated in other populations of neural progenitor cells.

Discussion {#sec3}
==========

ZNF644 Is a Co-regulator of G9a/H3K9me2-Mediated Gene Silencing during Neurogenesis {#sec3.1}
-----------------------------------------------------------------------------------

Our high-confidence interaction dataset recapitulated annotated complexes and many other recently reported protein-protein interactions ([Figures 1](#fig1){ref-type="fig"}A and 1B; [Table S1](#mmc2){ref-type="supplementary-material"}). Among the physical interactions identified, we functionally characterized the association of the C2H2-like ZF protein ZNF644, linked to high-grade myopia, with the HMTs G9a and GLP.

As with another documented interactor, WIZ, ZNF644 contains an atypical C2H2-like ZF motif, which we determined is necessary and sufficient for physical association with the G9a and GLP via direct binding to the SET domain ([Figures 1](#fig1){ref-type="fig"}D and 1E). These findings contrast with a recent report that a poorly conserved N-terminal region of ZNF644 is responsible for associating with G9a/GLP ([@bib6]) and imply that the conserved atypical C2H2-like ZF motifs of ZNF644 and WIZ constitute a common G9a/GLP recognition module. Point mutations in this atypical C2H2-like ZF motif that abolished interaction with G9a/GLP also failed to rescue *znf644a* and *znf644b* morphant phenotypes ([Figures 6](#fig6){ref-type="fig"}C and 6D). Furthermore, using shRNA-based knockdown assays in human cell culture, we determined that ZNF644 specifically co-regulates H3K9me2 levels but not other histone methylation marks, such as H3K9me3 ([Figure 1](#fig1){ref-type="fig"}F), suggesting a specialized function for ZNF644 related to G9a/H3K9me2-mediated gene silencing. Collectively, these data establish ZNF644 as a functionally relevant G9a/GLP-interacting protein and a specific co-regulator of H3K9me2 formation.

Multifaceted Regulation of Differentiation by Functional and Physical Interactions {#sec3.2}
----------------------------------------------------------------------------------

Shortly after 24 hpf, most zebrafish RPCs exit the cell cycle to generate post-mitotic differentiated progeny. These changes in RPC identity occur with concomitant suppression of multipotency-related and cell-cycle-related genes ([@bib15]), although little is known regarding the physical interactions or tissue-specific co-factors governing this transition. The regulatory properties of ZNF644 vis-à-vis G9a/H3K9me2 and expression patterns of the zebrafish paralogs in neural progenitor cell populations at 24 hpf (but reduced at later stages of retinal development) imply that they are co-regulators of H3K9me2-mediated gene silencing. We showed that disruption of *znf644a* or *znf644b* function leads to downstream defects in retinal differentiation that particularly manifest at 48--72 hpf.

Despite distinct multipotency-related gene-expression programs (e.g., *vsx2* expression in RPCs, but not in midbrain progenitors), similar histone methylation-related complexes may dictate gene silencing and cellular differentiation in distinct populations of neuronal progenitors. While loss of ZNF644 function in cell culture and in vivo leads to deficits in H3K9me2, additional investigations are needed to determine the precise molecular mechanism whereby ZNF644 regulates G9a/GLP activity. Although ZNF644 has multiple C2H2-like ZF motifs and evidence for a role in recruiting G9a/GLP to chromatin has been proposed ([@bib6]), we have failed to establish whether ZNF644 is truly capable of sequence-specific nucleic acid binding (our unpublished data). Neither human nor zebrafish ZNF644 contain the modular three-ZF array typically found in the DNA-binding variety of C2H2 ZF-containing proteins ([@bib25]). One possibility, however, is that ZNF644 may indirectly impart target gene specificity to G9a/GLP by serving as a molecular scaffold bridging HMTs to DNA/RNA-binding repressor molecules and/or other co-repressors to facilitate the stepwise, stable suppression of multipotency- and cell-cycle-related loci. Such a possibility is supported by findings in ESCs that WIZ serves as a physical scaffold bridging G9a/GLP to the CtBP co-repressor complex ([@bib46]). An alternative possibility, not necessarily mutually exclusive, is that ZNF644 directly stimulates the catalytic activity of G9a/GLP via direct physical interaction to the SET domain. Regardless, given the complex molecular mechanisms involved in G9a/GLP targeting in other contexts ([@bib10]), additional investigations are needed to define the precise functions of ZNF644 and WIZ in G9a/GLP-mediated silencing during neurogenesis.

Roles for G9a/GLP in regulating cell differentiation in other contexts, such as in HSPCs ([@bib13]) and ESCs ([@bib43]), have been reported. In neural progenitors, disruption of G9a/ZNF644 results in the extended maintenance of a proliferative progenitor identity, resulting in delayed formation of differentiated retinal neurons. We observed H3K9me2^+^ nuclei within populations of differentiated retinal neurons, which may represent expanded regions of H3K9me2-marked chromatin reported elsewhere ([@bib50]). The emergence of H3K9me2^+^ nuclei was preceded temporally by suppression of retinal progenitor identity and by expression of lineage commitment, suggesting that formation of expanded H3K9me2-marked chromatin may be a late-phase process occurring within differentiated neuronal cells. Given the reduced retinal expression at 48 or 72 hpf ([Figure S1](#mmc1){ref-type="supplementary-material"}D), when H3K9me2^+^ nuclei are detectable, *znf644a* and *znf644b* are unlikely to directly regulate formation of expanded regions of H3K9me2-marked chromatin in differentiated cell populations, but rather may regulate initial "seeding" of H3K9me2 marks at isolated genomic regions in retinal cells, at around 24 hpf, such as the promoter regions of *vsx2* and *ccnd1*, as we demonstrated.

Possible Insights into ZNF644 Function and High-Grade Myopia {#sec3.3}
------------------------------------------------------------

It is generally thought that longitudinal stretching (or lack thereof) can alter axial elongation, resulting in myopia or hyperopia ([@bib48]). However, some reports implicate developmental-related genes and signaling pathways in post-natal retinal growth ([@bib20], [@bib41]). In primates, disruption of the CMZ, which harbors a proliferating RPC niche, can cause high-grade myopia ([@bib44]). It is not obvious how SNPs in the coding sequence and 3′ UTR might affect ZNF644 function. Further investigations are needed to determine the precise role of ZNF644 (and impact of mutations associated with high-grade myopia) in controlling G9a/H3K9me2 during retinal growth and differentiation in adult stem cell populations.

Experimental Procedures {#sec4}
=======================

Affinity Purification and Mass Spectrometry {#sec4.1}
-------------------------------------------

Sequence-verified open reading frames from the Human ORFeome library (Open Biosystems) and UltimateORF collection (Invitrogen) from cDNA were cloned into pDONR221 or pDONR223. Replicate two-step enrichment AP-MS experiments were performed from HEK293 cell lysates essentially as previously described ([@bib30]). GFP-tagged AP-MS assays used Flp-In T-Rex HEK293 cells (a kind gift from Anne-Claude Gingras) cultured in media containing 250 μg/ml hygromycin and induced by treatment with 1 μg/ml doxycycline for 24 hr, followed by affinity purification using 1 μg of rabbit anti-GFP ABfinity recombinant antibody (Invitrogen, G10362). See [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for additional information.

Zebrafish Husbandry {#sec4.2}
-------------------

*Danio rerio* (AB strain) were raised and bred at 28°C in accordance with regulations on animal experimentation established by the Canadian Council on Animal Care. Care and procedures were approved by the University of Toronto Animal Care Committee. The *Tg(Isl2b:mGFP)* strain was a kind gift from Dr. Chi-Bin Chien (University of Utah).

Morpholino, mRNA Injections, and Statistics {#sec4.3}
-------------------------------------------

Embryos were injected at the 1- to 2-cell stage with antisense morpholino oligonucleotides (Gene Tools) and/or in vitro transcribed, capped full-length mRNA. Morpholino sequences, targeted splice junctions, and injection doses are listed in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. RT-PCR assays were performed from cDNA derived from RNA derived from de-yolked embryos (tails removed) using TRIzol (Invitrogen). In all cases, "n" refers to the number of individual embryos assayed in the experiments.

Whole-Mount In Situ Hybridization {#sec4.4}
---------------------------------

Whole-mount in situ hybridization (WISH) was essentially carried out as described in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. RNA antisense probes were obtained from the following sources: *znf644a* and *znf644b*, cloned from 24-hpf embryos; *lef1* and *otx2*, kind gifts from Ashley Bruce; ath5, a kind gift from Jeremy Kay; *rx3*, a kind gift from Pamela Raymond, *vsx2*, Open Biosystems; and *ccnd1* (cb161), ZIRC.

Chromatin Immunoprecipitation {#sec4.5}
-----------------------------

ChIP assays were performed using cells derived from ∼100 zebrafish heads at 48 hpf essentially as previously described ([@bib28]). In brief, cells were crosslinked using 1% formaldehyde and quenched with 0.125 M glycine. Sonication was performed by Bioruptor (Diagenode) using seven cycles. ChIP was performed using the EZ-ChIP kit (Millipore). H3K9me2 (AbCam, ab1220) and isotype control (AbCam, ab170191) antibodies were used at 2 μg per sample. See [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for further information.

Immunostaining and BrdU Incorporation Assays {#sec4.6}
--------------------------------------------

Samples were fixed in 4% paraformaldehyde and processed as described ([@bib51]). Sections were stained with Hoechst 33,342 and mounted with 80% glycerol. Antibodies used are listed in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. BrdU (5 mM) was injected into the tectal brain ventricle of 48-hpf embryos and fixed with 4% paraformaldehyde, followed by cryosection and immunostaining. Slides were treated with 20 U/mL BrdU, detected using an anti-BrdU antibody (Cedarlane, MCA2060), and imaged by confocal microscopy imaging.
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The accession number for znf644a reported in this paper is RefSeq: [NM_001278254.1](ncbi-n:NM_001278254.1){#intref0020}. The accession number for znf644b reported in this paper is RefSeq: [XM_003198781.4](ncbi-n:XM_003198781.4){#intref0025}.
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![ZNF644 Is a G9a/GLP-Interacting Protein and Co-regulator of H3K9me2\
(A) Physical interaction map of histone methylation-related complexes. Nodes represent proteins identified by AP-MS, black edges represent high-confidence interactions, and known interactions are in green.\
(B) Hierarchical clustering of bait interaction profile similarity. Colored boxes indicate proteins known to reside in the same complex.\
(C) (Top) Protein domain architecture of WIZ and ZNF644. (Bottom) Sequence alignment of atypical C2H2-like ZF motifs. Putative zinc ion-chelating residues are circled.\
(D) Summary of AP-MS analyses showing average peptide spectral counts of GFP-tagged forms of full-length WT ZNF644, the C1263A or H1283A point mutants, or the ZF8-containing C-terminal region only.\
(E) Western blot analysis of pulldown assays using GST-tagged WT, C1263A, or H1283A versions of the ZF8 domain of ZNF644 with the His-tagged G9a SET domain.\
(F) Western blot assays monitoring G9a, H3K9me2, H3K9me3, histone H3, and GAPDH levels in HEK293 cell lines expressing shRNAs targeting a non-silencing control, G9a, or ZNF644.](gr1){#fig1}

![Zebrafish *znf644* Paralogs Are Specifically Expressed In and Regulate the Development of Retinal and Midbrain Progenitor Cells\
(A) Conservation of C2H2-like ZF motifs between human and zebrafish ZNF644 genes.\
(B) Representative lateral views, retinal cross-sections, and midbrain cross-sections of whole-mount in situ hybridization (WISH) assays monitoring *znf644a* or *znf644b* expression at 24 hpf (n \> 15 in each group). Arrows denote the inner part of the central retinal epithelium.\
(C) Lateral views of *g9a* (20/32), *znf644a* (10/18), or *znf644b* (14/21) morphant embryos compared with WT (21/21). Dashed circles denote 2D area of the WT retina. Arrowheads denote the dorsal hindbrain region.\
(D) Quantitation (mean ± SD) of retinal 2D cross-sectional area (μm^2^) of *znf644a*, *znf644b*, or *g9a* morphants relative to WT embryos. Error bars represent SD. ^∗^p \< 0.005, Student\'s t test.\
(E) RT-PCR assays monitoring unspliced (unspl) and spliced (spl) *znf644a* or *znf644b* transcripts at 24 hpf.](gr2){#fig2}

![*znf644a* and *znf644b* Are Required for H3K9me2-Mediated Gene Silencing in the Forming Retina\
(A) Frequency and distance from TSS at which H3K9me2 peaks were identified in WT, *znf644a*, and *znf644b* morphants.\
(B) Venn diagram illustrating the number and overlap of H3K9me2 peaks at 48 hpf in z*nf644a* or *znf644b* morphants or WT embryos.\
(C) ChIP-PCR assays monitoring H3K9me2 levels near the TSSs of *vsx2* or *ccnd1* genes at 48 hpf.\
(D) WISH assays monitoring expression of progenitor or proneural genes in WT, *znf644a*, or *znf644b* morphant retinas. Arrows highlight expression domains.](gr3){#fig3}

![*znf644a* and *znf644b* Morphant Retinas Are Composed of Distinct Populations of Retinal Cells with Differing Characteristics\
(A) Immunostaining of retinal cross-sections monitoring BrdU incorporation and PCNA^+^ cells at 48 hpf in WT, *znf644a*, and *znf644b* morphants.\
(B) Quantitation of BrdU^+^ cells/μm^2^ in central retina of WT, *znf644a*, or *znf644b* morphants at 48 hpf (n = 3 for each group). Error bars represent SD. ^∗^p \< 0.05, Student\'s t test.\
(C--E) Immunostaining of pH3 expression in retinal cross-sections at 48 and 72 hpf in WT, and *znf644a* morphants (C). Quantitation of pH3^+^ cells/μm^2^ in the central retina of WT, *znf644a*, or *znf644b* morphants at (D) 48 hpf (n = 5 for each group) and (E) 72 hpf (n = 2 for each group). Quantitation represented as mean ± SD.\
(F) Immunostaining monitoring marker protein expression in retinal cross-sections. At 72 hpf, amacrine cells express GABA, bipolar neurons express PKC, and cone photoreceptors express Zpr1.\
White arrows highlight populations of proliferative or differentiated cells.](gr4){#fig4}

![*znf644a* and *znf644b* Morphant Retinas Exhibit Distinct Cellular Defects\
(A) Immunostaining of retinal cross-sections of Vsx2 (red), Pax6 (red), Isl2b (green), or H3K9me2 (red) in WT or *znf644a* morphant embryos at indicated time points. Vsx2 expression at 48 hpf marks proliferating RPCs in the CMZ (gray arrows) and in a subpopulation of bipolar neurons in the central retina (yellow arrows). Pax6 expression marks amacrine cells and a subset of RGCs, and Isl2b expression marks a subset of RGCs. Differentiated retinal neurons with H3K9me2^+^ nuclei are highlighted.\
(B and C) Immunostaining monitoring cleaved Caspase3 (red) in retinal cross-sections from WT, *g9a*, or *znf644b* morphant embryos at 48 or 72 hpf (B). Yellow arrows highlight Caspase3^+^ apoptotic cells. (C) Quantitation of Caspase3^+^ cells in WT, *znf644a* morphant, or *znf644b* morphant retinas with or without co-injection of p53-MO at 72 hpf. Quantitation represented as mean ± SD (n=3 for each group). ^∗^p \< 0.05, ^∗∗^p \< 0.005, ^∗∗∗^p \< 0.0005, Student\'s t test.](gr5){#fig5}

![The Retinal Functions of *znf644a* and *znf644b* Are Dependent on Functional and Physical Interactions with *g9a*\
(A) Immunostaining of cleaved Caspase3 (red) in retinal cross-sections of embryos injected with individual or combined subphenotypic doses of g9a-MO, znf644a-MO, or znf644b-MO (n = 3 in each group). Yellow arrows highlight apoptotic cells.\
(B) (Top) Immunostaining of PCNA (n = 6 in each group) in retinal cross-sections from embryos injected with individual and combined subphenotypic doses of MOs (n = 6 in each group). Yellow arrows denote the position of the PCNA+ population. (Bottom) WISH assays monitoring the expression of *vsx2* in retinal cross-sections of embryos injected with individual subphenotypic doses (n = 10 in each group) and combined subphenotypic co-injection of g9a-MO and znf644a-MO (n = 10), g9a-MO and znf644b-MO (n = 13), and znf644a-MO and znf644b-MO (n = 10). Red arrows denote the position of the vsx2 expressing cells.\
(C) (Top) WISH assays in retinal cross-sections monitoring *vsx2* expression at 48 hpf in *znf644a* morphant embryos rescued by co-injection of either WT human ZNF644 mRNA (n = 12) or C1263A mutant mRNA (n = 9). (Bottom) Immunostaining of retinal cross-sections monitoring PCNA expression at 48 hpf showing rescue of *znf644b* morphants by co-injection of WT human ZNF644 mRNA (n = 3) but not C1263A mutants (n = 3).\
(D) (Top) WISH assays in retinal cross-sections at 48 hpf monitoring *vsx2* expression from *znf644b* morphant embryos rescued by co-injection of human WT ZNF644 mRNA (n = 14) or C1263A ZNF644 mutant mRNA (n = 9). (Bottom) Immunostaining of retinal cross-sections monitoring cleaved Caspase3 at 72 hpf in *znf644b* morphant embryos rescued by co-injection of WT human ZNF644 mRNA (n = 3) or a C1263A mutant (n = 3). Red arrows highlight *vsx2* expression domains, and yellow arrows highlight PCNA+ cell populations (C) or apoptotic cells (D).](gr6){#fig6}

![The Retinal Defects of *g9a*, *znf644a*, and *znf644b* Morphants Are Recapitulated in the Midbrain\
(A) WISH assays monitoring *ccnd1* expression in WT, *znf644a*, or *znf644b* morphant midbrain cross-sections at 48 hpf. Arrows indicate mislocalized *ccnd1* expression.\
(B) Immunostaining of cleaved Caspase3 in *g9a* or *znf644b* morphant midbrain cross-sections at 72 hpf and rescue by p53-MO (n = 3 in each group). Arrows denote the position of Caspase3+ cells.\
(C) Immunostaining of PCNA in WT or *znf644a* morphant midbrain cross-sections (n = 3 in each group). Arrows denote the position of PCNA+ cells.](gr7){#fig7}
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